Maternal serum insulin-like growth factor-I  by Wiwanitkit, Viroj
Available online at www.sciencedirect.comScienceDirect
Journal of the Chinese Medical Association 77 (2014) 217
www.jcma-online.comLetter to the Editorhttp://d
1726-4Maternal serum insulin-like growth factor-ITo the Editor,
The recent report on maternal insulin-like growth factor-I is
very interesting.1 Yang et al. concluded that “maternal serum
IGF-I is significantly related to GA, maternal BW, and BMI
during pregnancy.”1 In fact, there are some previous reports on
this issue. Pathmaperuma et al. made a completely different
observation.2 In their report, it was reported that serum IGF-I
“did not correlate with newborn or maternal anthropometric
indices”.2 There are many facts to be considered. First, the
level of serum IGF-I is sometimes mentioned to vary between
difference races,2 and this might be the possible explanation
for different observations in different settings. Second, the
present report used only patient history to conclude that the
patient was in fact “healthy”. There are many possible
abnormalities that are occult, and are only biochemical
abnormalities in the mothers. Third, the techniques for deter-
mination of IGF-I level should be discussed. It would appear
that the diagnostic properties seem to be variable from test kit
to test kit.3x.doi.org/10.1016/j.jcma.2014.03.002
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